Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor()

PURPOSE: The incidence of anaplastic lymphoma kinase (ALK) rearrangement in pulmonary sarcomatoid carcinoma (PSC) is controversial. In this study, we aimed to reveal the reliable frequency and the clinical-pathologic characteristics of pulmonary sarcomatoid carcinoma (PSC) with ALK rearrangement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xinru, Zhang, Yu, Lu, Jiabin, Xu, Chunwei, Liang, Jianzhong, Wang, Fang, Sun, Wenyong, Fang, Sangao, Yuan, Jingping, Wang, Huijuan, Wang, Hui, Liu, Xuewen, Chen, Likun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225784/
https://www.ncbi.nlm.nih.gov/pubmed/28081478
http://dx.doi.org/10.1016/j.tranon.2016.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225784/
https://www.ncbi.nlm.nih.gov/pubmed/28081478
http://dx.doi.org/10.1016/j.tranon.2016.11.009

Ejemplares similares